Blood Preparation Market Size By Product (Whole Blood, Blood Components, Blood Derivatives), By Application (Thrombocytosis, Pulmonary Embolism, Renal Impairment, Angina Blood Vessel Complications), By Antithrombotic and Anticoagulants (Platelet Aggregation Inhibitors, Fibrinolytics, Anticoagulants), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, China, Japan, Brazil, Mexico, South Africa), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024

Published Date: October 2016 | 168 Pages | Report ID: GMI790 Report Format: PDF

Inquiry Before Buying   Request Sample

Report Content

Chapter 1.    Methodology and Scope

1.1.    Research Methodology

1.1.1.    Initial data exploration

1.1.2.    Statistical modeling and forecast

1.1.3.    Industry insights and validation                

1.2.    Data Sources

Chapter 2.    Executive Summary

2.1.    Blood preparation industry 3600 synopsis, 2012 - 2024

2.1.1.    Business trends

2.1.2.    Product trends

2.1.3.    Application trends

2.1.4.    Regional trends

Chapter 3.    Blood preparation Industry Insights

3.1.    Industry segmentation

3.2.    Industry Size and forecast, 2012 - 2024

3.3.    Industry Impact forces

3.3.1.    Growth drivers

3.3.1.1.    Increasing geriatric population 

3.3.1.2.    Presence of advanced technology for blood preparation and storage

3.3.1.3.    Increasing usage of plasma in pharmaceutical industry

3.3.1.4.    Rising demand for whole blood and blood components transfusion

3.3.2.    Industry pitfalls & challenges

3.3.2.1.    Risk of blood transmitted diseases and growing blood substitutes

3.4.    Growth potential analysis

3.5.    Porter’s analysis

3.6.    PESTEL analysis

Chapter 4.      Blood preparation Product Insights    

4.1.    Blood preparation market share by Product, 2015 & 2024

4.2.    Whole Blood

4.2.1.    Market estimates by region, 2012-2024 (USD Million)

4.2.2.    Red Cells

 4.2.2.1.    Market estimates by region, 2012-2024 (USD Million)

4.2.3.    Granulocytes

 4.2.3.1.    Market estimates by region, 2012-2024 (USD Million)

4.2.4.   Plasma

4.2.4.1.    Market estimates by region, 2012-2024 (USD Million)

4.2.5.    Platelets

4.2.5.1.    Market estimates by region, 2012-2024 (USD Million)

4.3.    Blood Components

4.3.1.    Market estimates by region, 2012-2024 (USD Million)

4.3.2.    Whole Blood Components

4.3.2.1.    Market estimates by region, 2012-2024 (USD Million)

4.3.3.    Packed Red Cells

4.3.3.1.    Market estimates by region, 2012-2024 (USD Million)

4.3.4.    Leucocyte Reduced Red Blood Cells

4.3.4.1.    Market estimates by region, 2012-2024 (USD Million)

4.3.5.    Frozen Plasma

4.3.5.1.    Market estimates by region, 2012-2024 (USD Million)

4.3.6.    Platelet Concentrate

4.3.6.1.    Market estimates by region, 2012-2024 (USD Million)

4.3.7.    Cryoprecipitate

 4.3.7.1.    Market estimates by region, 2012-2024 (USD Million)

4.4.    Blood Derivatives

4.4.1.    Market estimates by region, 2012-2024 (USD Million)

Chapter 5.    Blood preparation by Application

5.1.    Blood preparation market share by application, 2015 & 2024

5.2.    Pulmonary embolism

5.2.1.    Market estimates by region, 2012-2024 (USD Million)

5.3.    Thrombocytosis

5.3.1.    Market estimates by region, 2012-2024 (USD Million)

5.4.    Renal impairment

5.4.1.    Market estimates by region, 2012-2024 (USD Million)

5.5.    Angina blood vessel complications

5.5.1.    Market estimates by region, 2012-2024 (USD Million)

5.6.    Others

5.6.1.    Market estimates by region, 2012-2024 (USD Million)

Chapter 6.    Blood preparation by Antithrombotic and Anticoagulants

6.1.    Blood preparation market share by antithrombotic and anticoagulants, 2015 & 2024

6.2.    Antithrombotic

6.2.1.    Market estimates by region, 2012-2024 (USD Million)

6.2.2.    Platelet Aggregation Inhibitors

6.2.2.1.    Market estimates by region, 2012-2024 (USD Million)

6.2.2.2.    Glycoprotein Inhibitors

                6.2.2.2.1.    Market estimates by region, 2012-2024 (USD Million)

6.2.2.3.    COX Inhibitors

               6.2.2.3.1.    Market estimates by region, 2012-2024 (USD Million)

6.2.2.4.    ADP Antagonists

               6.2.2.4.1.    Market estimates by region, 2012-2024 (USD Million)

6.2.2.5.    Phosphodiesterase Inhibitors

              6.2.2.5.1.    Market estimates by region, 2012-2024 (USD Million)

6.2.3.    Fibrinolytics

6.2.3.1.    Market estimates by region, 2012-2024 (USD Million)

6.2.3.2.    Tissue Plasminogen Activator (tPA)

6.2.3.2.1.    Market estimates by region, 2012-2024 (USD Million)

6.2.3.3.    Streptokinase

               6.2.3.3.1.    Market estimates by region, 2012-2024 (USD Million)

6.2.3.4.    Urokinase

                6.2.3.4.1.    Market estimates by region, 2012-2024 (USD Million)

6.3.    Anticoagulants

6.3.1.    Market estimates by region, 2012-2024 (USD Million)

6.3.2.    Heparins

6.3.2.1.    Market estimates by region, 2012-2024 (USD Million)

6.3.2.2.    Unfractionated Heparin

               6.3.2.2.1.    Market estimates by region, 2012-2024 (USD Million)

6.3.2.3.    Low Molecular Weight Heparin (LMWH)

               6.3.2.3.1.    Market estimates by region, 2012-2024 (USD Million)

6.3.2.4.    Ultra-low Molecular Weight Heparin

              6.3.2.4.1.    Market estimates by region, 2012-2024 (USD Million)

6.3.3.    Vitamin K Antagonists

6.3.3.1.    Market estimates by region, 2012-2024 (USD Million)

6.3.4.    Direct Thrombin Inhibitors

6.3.4.1.    Market estimates by region, 2012-2024 (USD Million)

6.3.5.    Direct Factor Xa Inhibitors

6.3.5.1.    Market estimates by region, 2012-2024 (USD Million)

Chapter 7.    Blood preparation Regional Insights

7.1.    Blood preparation market share by region, 2015 & 2024

7.2.    North America Blood preparation market

7.2.1.    Market estimates by product, 2012-2024 (USD Million)  

7.2.2.    Market estimates by application, 2012-2024 (USD Million)

7.2.3.    Market estimates by antithrombotic and anticoagulants, 2012-2024 (USD Million)

7.2.4.    U.S.

7.2.4.1.    Market estimates by product, 2012-2024 (USD Million)  

7.2.4.2.    Market estimates by application, 2012-2024 (USD Million)

7.2.4.3.    Market estimates by antithrombotic and anticoagulants, 2012-2024 (USD Million)

7.2.5.    Canada

7.2.5.1.    Market estimates by product, 2012-2024 (USD Million)  

7.2.5.2.    Market estimates by application, 2012-2024 (USD Million)

7.2.5.3.    Market estimates by antithrombotic and anticoagulants, 2012-2024 (USD Million)

7.3.    Europe Blood preparation market 

7.3.1.    Market estimates by product, 2012-2024 (USD Million)  

7.3.2.    Market estimates by application, 2012-2024 (USD Million)

7.3.3.    Market estimates by antithrombotic and anticoagulants, 2012-2024 (USD Million)

7.3.4.    Germany

7.3.4.1.    Market estimates by product, 2012-2024 (USD Million)  

7.3.4.2.    Market estimates by application, 2012-2024 (USD Million)

7.3.4.3.    Market estimates by antithrombotic and anticoagulants, 2012-2024 (USD Million)

7.3.5.    UK

7.3.5.1.    Market estimates by product, 2012-2024 (USD Million)  

7.3.5.2.    Market estimates by application, 2012-2024 (USD Million)

7.3.5.3.    Market estimates by antithrombotic and anticoagulants, 2012-2024 (USD Million)

7.3.6.    France

7.3.6.1.    Market estimates by product, 2012-2024 (USD Million)  

7.3.6.2.    Market estimates by application, 2012-2024 (USD Million)

7.3.6.3.    Market estimates by antithrombotic and anticoagulants, 2012-2024 (USD Million)

7.3.7.    Italy

7.3.7.1.    Market estimates by product, 2012-2024 (USD Million)  

7.3.7.2.    Market estimates by application, 2012-2024 (USD Million)

7.3.7.3.    Market estimates by antithrombotic and anticoagulants, 2012-2024 (USD Million)

7.4.    Asia Pacific Blood preparation market 

7.4.1.    Market estimates by product, 2012-2024 (USD Million)  

7.4.2.    Market estimates by application, 2012-2024 (USD Million)

7.4.3.    Market estimates by antithrombotic and anticoagulants, 2012-2024 (USD Million)

7.4.4.    China

7.4.4.1.    Market estimates by product, 2012-2024 (USD Million)  

7.4.4.2.    Market estimates by application, 2012-2024 (USD Million)

7.4.4.3.    Market estimates by antithrombotic and anticoagulants, 2012-2024 (USD Million)

7.4.5.    Japan

7.4.5.1.    Market estimates by product, 2012-2024 (USD Million)  

7.4.5.2.    Market estimates by application, 2012-2024 (USD Million)

7.4.5.3.    Market estimates by antithrombotic and anticoagulants, 2012-2024 (USD Million)

7.5.    Latin America Blood preparation market

7.5.1.    Market estimates by product, 2012-2024 (USD Million)  

7.5.2.    Market estimates by application, 2012-2024 (USD Million)

7.5.3.    Market estimates by antithrombotic and anticoagulants, 2012-2024 (USD Million)

7.5.4.    Brazil

7.5.4.1.    Market estimates by product, 2012-2024 (USD Million)  

7.5.4.2.    Market estimates by application, 2012-2024 (USD Million)

7.5.4.3.    Market estimates by antithrombotic and anticoagulants, 2012-2024 (USD Million)

7.5.5.    Mexico

7.5.5.1.    Market estimates by product, 2012-2024 (USD Million)  

7.5.5.2.    Market estimates by application, 2012-2024 (USD Million)

7.5.5.3.    Market estimates by antithrombotic and anticoagulants, 2012-2024 (USD Million)

7.6.    MEA Blood preparation market

7.6.1.    Market estimates by product, 2012-2024 (USD Million)  

7.6.2.    Market estimates by application, 2012-2024 (USD Million)

7.6.3.    Market estimates by antithrombotic and anticoagulants, 2012-2024 (USD Million)

7.6.4.    South Africa

7.6.4.1.    Market estimates by product, 2012-2024 (USD Million)  

7.6.4.2.    Market estimates by application, 2012-2024 (USD Million)

7.6.4.3.    Market estimates by antithrombotic and anticoagulants, 2012-2024 (USD Million)

Chapter 8.    Company Profiles                    

 8.1.    AstraZeneca

8.1.1.    Business Overview

8.1.2.    Financial Data

8.1.3.    Product Landscape  

8.1.4.    Strategic Outlook 

8.2.    Baxter Healthcare

8.2.1.    Business Overview

8.2.2.    Financial Data

8.2.3.    Product Landscape  

8.2.4.    Strategic Outlook

8.3.    Bristol-Myers Squibb

8.3.1.    Business Overview

8.3.2.    Financial Data  

8.3.3.    Product Landscape  

8.3.4.    Strategic Outlook

8.4.    Celgene

8.4.1.    Business Overview

8.4.2.    Financial Data

8.4.3.    Product Landscape  

8.4.4.    Strategic Outlook

8.5.    GlaxoSmithKline PLC

8.5.1.    Business Overview

8.5.2.    Financial Data

8.5.3.    Product Landscape  

8.5.4.    Strategic Outlook

8.6.    Hisunny Chemical Co

8.6.1.    Business Overview

8.6.2.    Financial Data

8.6.3.    Product Landscape  

8.6.4.    Strategic Outlook

8.7.    Leo Pharma

8.7.1.    Business Overview

8.7.2.    Financial Data

8.7.3.    Product Landscape  

8.7.4.    Strategic Outlook

8.8.    Pfizer

8.8.1.    Business Overview

8.8.2.    Financial Data

8.8.3.    Product Landscape  

8.8.4.    Strategic Outlook

8.9.    Sanofi Aventis

8.9.1.    Business Overview

8.9.2.    Financial Data

8.9.3.    Product Landscape  

8.9.4.    Strategic Outlook

8.10.    Shandong East Chemical Industry Co

8.10.1.    Business Overview

8.10.2.    Financial Data

8.10.3.    Product Landscape  

8.10.4.    Strategic Outlook
 

Data Tables
TABLE 1    Blood preparation industry 3600 synopsis, 2012 - 2024
TABLE 2    Blood preparation market, by product, 2012 - 2024 (USD Million)
TABLE 3    Blood preparation market, by application, 2012 - 2024 (USD Million)
TABLE 4    Blood preparation market, by antithrombotic and anticoagulants, 2012 - 2024 (USD Million)
TABLE 5    Blood preparation market, by region, 2012 - 2024 (USD Million)
TABLE 6    Growth drivers
TABLE 7    Industry pitfalls & challenges
TABLE 8    North America Blood preparation market, by product, 2012 - 2024 (USD Million)
TABLE 9    North America Blood preparation market, by whole blood, 2012 - 2024 (USD Million)
TABLE 10    North America Blood preparation market, by blood components, 2012 - 2024 (USD Million)
TABLE 11    North America Blood preparation market, by blood derivatives, 2012 - 2024 (USD Million)
TABLE 12    North America Blood preparation market, by application, 2012 - 2024 (USD Million)
TABLE 13    North America Blood preparation market, by antithrombotic and anticoagulants, 2012 - 2024 (USD Million)
TABLE 14    North America Blood preparation market, by platelet aggregation inhibitors, 2012 - 2024 (USD Million)
TABLE 15    North America Blood preparation market, by fibrinolytic, 2012 - 2024 (USD Million)
TABLE 16    North America Blood preparation market, by anticoagulants, 2012 - 2024 (USD Million)
TABLE 17    North America Blood preparation market, by heparin, 2012 - 2024 (USD Million)
TABLE 18    U.S. Blood preparation market, by product, 2012 - 2024 (USD Million)
TABLE 19    U.S. Blood preparation market, by application, 2012 - 2024 (USD Million)
TABLE 20    U.S. Blood preparation market, by antithrombotic and anticoagulants, 2012 - 2024 (USD Million)
TABLE 21    U.S. Blood preparation market, by product, 2012 - 2024 (USD Million)
TABLE 22    U.S. Blood preparation market, by whole blood, 2012 - 2024 (USD Million)
TABLE 23    U.S. Blood preparation market, by blood components, 2012 - 2024 (USD Million)
TABLE 24    U.S. Blood preparation market, by blood derivatives, 2012 - 2024 (USD Million)
TABLE 25    U.S. Blood preparation market, by application, 2012 - 2024 (USD Million)
TABLE 26    U.S. Blood preparation market, by antithrombotic and anticoagulants, 2012 - 2024 (USD Million)
TABLE 27    U.S. Blood preparation market, by platelet aggregation inhibitors, 2012 - 2024 (USD Million)
TABLE 28    U.S. Blood preparation market, by fibrinolytic, 2012 - 2024 (USD Million)
TABLE 29    U.S. Blood preparation market, by anticoagulants, 2012 - 2024 (USD Million)
TABLE 30    U.S. Blood preparation market, by heparin, 2012 - 2024 (USD Million)
TABLE 31    U.S. Blood preparation market, by product, 2012 - 2024 (USD Million)
TABLE 32    U.S. Blood preparation market, by application, 2012 - 2024 (USD Million)
TABLE 33    U.S. Blood preparation market, by antithrombotic and anticoagulants, 2012 - 2024 (USD Million)
TABLE 34    Canada Blood preparation market, by product, 2012 - 2024 (USD Million)
TABLE 35    Canada Blood preparation market, by whole blood, 2012 - 2024 (USD Million)
TABLE 36    Canada Blood preparation market, by blood components, 2012 - 2024 (USD Million)
TABLE 37    Canada Blood preparation market, by blood derivatives, 2012 - 2024 (USD Million)
TABLE 38    Canada Blood preparation market, by application, 2012 - 2024 (USD Million)
TABLE 39    Canada Blood preparation market, by antithrombotic and anticoagulants, 2012 - 2024 (USD Million)
TABLE 40    Canada Blood preparation market, by platelet aggregation inhibitors, 2012 - 2024 (USD Million)
TABLE 41    Canada Blood preparation market, by fibrinolytic, 2012 - 2024 (USD Million)
TABLE 42    Canada Blood preparation market, by anticoagulants, 2012 - 2024 (USD Million)
TABLE 43    Canada Blood preparation market, by heparin, 2012 - 2024 (USD Million)
TABLE 44    Europe Blood preparation market, by product, 2012 - 2024 (USD Million)
TABLE 45    Europe Blood preparation market, by whole blood, 2012 - 2024 (USD Million)
TABLE 46    Europe Blood preparation market, by blood components, 2012 - 2024 (USD Million)
TABLE 47    Europe Blood preparation market, by blood derivatives, 2012 - 2024 (USD Million)
TABLE 48    Europe Blood preparation market, by application, 2012 - 2024 (USD Million)
TABLE 49    Europe Blood preparation market, by antithrombotic and anticoagulants, 2012 - 2024 (USD Million)
TABLE 50    Europe Blood preparation market, by platelet aggregation inhibitors, 2012 - 2024 (USD Million)
TABLE 51    Europe Blood preparation market, by fibrinolytic, 2012 - 2024 (USD Million)
TABLE 52    Europe Blood preparation market, by anticoagulants, 2012 - 2024 (USD Million)
TABLE 53    Europe Blood preparation market, by heparin, 2012 - 2024 (USD Million)
TABLE 54    Germany Blood preparation market, by product, 2012 - 2024 (USD Million)
TABLE 55    Germany Blood preparation market, by whole blood, 2012 - 2024 (USD Million)
TABLE 56    Germany Blood preparation market, by blood components, 2012 - 2024 (USD Million)
TABLE 57    Germany Blood preparation market, by blood derivatives, 2012 - 2024 (USD Million)
TABLE 58    Germany Blood preparation market, by application, 2012 - 2024 (USD Million)
TABLE 59    Germany Blood preparation market, by antithrombotic and anticoagulants, 2012 - 2024 (USD Million)
TABLE 60    Germany Blood preparation market, by platelet aggregation inhibitors, 2012 - 2024 (USD Million)
TABLE 61    Germany Blood preparation market, by fibrinolytic, 2012 - 2024 (USD Million)
TABLE 62    Germany Blood preparation market, by anticoagulants, 2012 - 2024 (USD Million)
TABLE 63    Germany Blood preparation market, by heparin, 2012 - 2024 (USD Million)
TABLE 64    UK Blood preparation market, by product, 2012 - 2024 (USD Million)
TABLE 65    UK Blood preparation market, by whole blood, 2012 - 2024 (USD Million)
TABLE 66    UK Blood preparation market, by blood components, 2012 - 2024 (USD Million)
TABLE 67    UK Blood preparation market, by blood derivatives, 2012 - 2024 (USD Million)
TABLE 68    UK Blood preparation market, by application, 2012 - 2024 (USD Million)
TABLE 69    UK Blood preparation market, by antithrombotic and anticoagulants, 2012 - 2024 (USD Million)
TABLE 70    UK Blood preparation market, by platelet aggregation inhibitors, 2012 - 2024 (USD Million)
TABLE 71    UK Blood preparation market, by fibrinolytic, 2012 - 2024 (USD Million)
TABLE 72    UK Blood preparation market, by anticoagulants, 2012 - 2024 (USD Million)
TABLE 73    UK Blood preparation market, by heparin, 2012 - 2024 (USD Million)
TABLE 74    France Blood preparation market, by product, 2012 - 2024 (USD Million)
TABLE 75    France Blood preparation market, by whole blood, 2012 - 2024 (USD Million)
TABLE 76    France Blood preparation market, by blood components, 2012 - 2024 (USD Million)
TABLE 77    France Blood preparation market, by blood derivatives, 2012 - 2024 (USD Million)
TABLE 78    France Blood preparation market, by application, 2012 - 2024 (USD Million)
TABLE 79    France Blood preparation market, by antithrombotic and anticoagulants, 2012 - 2024 (USD Million)
TABLE 80    France Blood preparation market, by platelet aggregation inhibitors, 2012 - 2024 (USD Million)
TABLE 81    France Blood preparation market, by fibrinolytic, 2012 - 2024 (USD Million)
TABLE 82    France Blood preparation market, by anticoagulants, 2012 - 2024 (USD Million)
TABLE 83    France Blood preparation market, by heparin, 2012 - 2024 (USD Million)
TABLE 84    Italy Blood preparation market, by product, 2012 - 2024 (USD Million)
TABLE 85    Italy Blood preparation market, by whole blood, 2012 - 2024 (USD Million)
TABLE 86    Italy Blood preparation market, by blood components, 2012 - 2024 (USD Million)
TABLE 87    Italy Blood preparation market, by blood derivatives, 2012 - 2024 (USD Million)
TABLE 88    Italy Blood preparation market, by application, 2012 - 2024 (USD Million)
TABLE 89    Italy Blood preparation market, by antithrombotic and anticoagulants, 2012 - 2024 (USD Million)
TABLE 90    Italy Blood preparation market, by platelet aggregation inhibitors, 2012 - 2024 (USD Million)
TABLE 91    Italy Blood preparation market, by fibrinolytic, 2012 - 2024 (USD Million)
TABLE 92    Italy Blood preparation market, by anticoagulants, 2012 - 2024 (USD Million)
TABLE 93    Italy Blood preparation market, by heparin, 2012 - 2024 (USD Million)
TABLE 94    Asia Pacific Blood preparation market, by product, 2012 - 2024 (USD Million)
TABLE 95    Asia Pacific Blood preparation market, by whole blood, 2012 - 2024 (USD Million)
TABLE 96    Asia Pacific Blood preparation market, by blood components, 2012 - 2024 (USD Million)
TABLE 97    Asia Pacific Blood preparation market, by blood derivatives, 2012 - 2024 (USD Million)
TABLE 98    Asia Pacific Blood preparation market, by application, 2012 - 2024 (USD Million)
TABLE 99    Asia Pacific Blood preparation market, by antithrombotic and anticoagulants, 2012 - 2024 (USD Million)
TABLE 100    Asia Pacific Blood preparation market, by platelet aggregation inhibitors, 2012 - 2024 (USD Million)
TABLE 101    Asia Pacific Blood preparation market, by fibrinolytic, 2012 - 2024 (USD Million)
TABLE 102    Asia Pacific Blood preparation market, by anticoagulants, 2012 - 2024 (USD Million)
TABLE 103    Asia Pacific Blood preparation market, by heparin, 2012 - 2024 (USD Million)
TABLE 104    China Blood preparation market, by product, 2012 - 2024 (USD Million)
TABLE 105    China Blood preparation market, by whole blood, 2012 - 2024 (USD Million)
TABLE 106    China Blood preparation market, by blood components, 2012 - 2024 (USD Million)
TABLE 107    China Blood preparation market, by blood derivatives, 2012 - 2024 (USD Million)
TABLE 108    China Blood preparation market, by application, 2012 - 2024 (USD Million)
TABLE 109    China Blood preparation market, by antithrombotic and anticoagulants, 2012 - 2024 (USD Million)
TABLE 110    China Blood preparation market, by platelet aggregation inhibitors, 2012 - 2024 (USD Million)
TABLE 111    China Blood preparation market, by fibrinolytic, 2012 - 2024 (USD Million)
TABLE 112    China Blood preparation market, by anticoagulants, 2012 - 2024 (USD Million)
TABLE 113    China Blood preparation market, by heparin, 2012 - 2024 (USD Million)
TABLE 114    Japan Blood preparation market, by product, 2012 - 2024 (USD Million)
TABLE 115    Japan Blood preparation market, by whole blood, 2012 - 2024 (USD Million)
TABLE 116    Japan Blood preparation market, by blood components, 2012 - 2024 (USD Million)
TABLE 117    Japan Blood preparation market, by blood derivatives, 2012 - 2024 (USD Million)
TABLE 118    Japan Blood preparation market, by application, 2012 - 2024 (USD Million)
TABLE 119    Japan Blood preparation market, by antithrombotic and anticoagulants, 2012 - 2024 (USD Million)
TABLE 120    Japan Blood preparation market, by platelet aggregation inhibitors, 2012 - 2024 (USD Million)
TABLE 121    Japan Blood preparation market, by fibrinolytic, 2012 - 2024 (USD Million)
TABLE 122    Japan Blood preparation market, by anticoagulants, 2012 - 2024 (USD Million)
TABLE 123    Japan Blood preparation market, by heparin, 2012 - 2024 (USD Million)
TABLE 124    Latin America Blood preparation market, by product, 2012 - 2024 (USD Million)
TABLE 125    Latin America Blood preparation market, by whole blood, 2012 - 2024 (USD Million)
TABLE 126    Latin America Blood preparation market, by blood components, 2012 - 2024 (USD Million)
TABLE 127    Latin America Blood preparation market, by blood derivatives, 2012 - 2024 (USD Million)
TABLE 128    Latin America Blood preparation market, by application, 2012 - 2024 (USD Million)
TABLE 129    Latin America Blood preparation market, by antithrombotic and anticoagulants, 2012 - 2024 (USD Million)
TABLE 130    Latin America Blood preparation market, by platelet aggregation inhibitors, 2012 - 2024 (USD Million)
TABLE 131    Latin America Blood preparation market, by fibrinolytic, 2012 - 2024 (USD Million)
TABLE 132    Latin America Blood preparation market, by anticoagulants, 2012 - 2024 (USD Million)
TABLE 133    Latin America Blood preparation market, by heparin, 2012 - 2024 (USD Million)
TABLE 134    Brazil Blood preparation market, by product, 2012 - 2024 (USD Million)
TABLE 135    Brazil Blood preparation market, by whole blood, 2012 - 2024 (USD Million)
TABLE 136    Brazil Blood preparation market, by blood components, 2012 - 2024 (USD Million)
TABLE 137    Brazil Blood preparation market, by blood derivatives, 2012 - 2024 (USD Million)
TABLE 138    Brazil Blood preparation market, by application, 2012 - 2024 (USD Million)
TABLE 139    Brazil Blood preparation market, by antithrombotic and anticoagulants, 2012 - 2024 (USD Million)
TABLE 140    Brazil Blood preparation market, by platelet aggregation inhibitors, 2012 - 2024 (USD Million)
TABLE 141    Brazil Blood preparation market, by fibrinolytic, 2012 - 2024 (USD Million)
TABLE 142    Brazil Blood preparation market, by anticoagulants, 2012 - 2024 (USD Million)
TABLE 143    Brazil Blood preparation market, by heparin, 2012 - 2024 (USD Million)
TABLE 144    Mexico Blood preparation market, by product, 2012 - 2024 (USD Million)
TABLE 145    Mexico Blood preparation market, by whole blood, 2012 - 2024 (USD Million)
TABLE 146    Mexico Blood preparation market, by blood components, 2012 - 2024 (USD Million)
TABLE 147    Mexico Blood preparation market, by blood derivatives, 2012 - 2024 (USD Million)
TABLE 148    Mexico Blood preparation market, by application, 2012 - 2024 (USD Million)
TABLE 149    Mexico Blood preparation market, by antithrombotic and anticoagulants, 2012 - 2024 (USD Million)
TABLE 150    Mexico Blood preparation market, by platelet aggregation inhibitors, 2012 - 2024 (USD Million)
TABLE 151    Mexico Blood preparation market, by fibrinolytic, 2012 - 2024 (USD Million)
TABLE 152    Mexico Blood preparation market, by anticoagulants, 2012 - 2024 (USD Million)
TABLE 153    Mexico Blood preparation market, by heparin, 2012 - 2024 (USD Million)
TABLE 154    MEA Blood preparation market, by product, 2012 - 2024 (USD Million)
TABLE 155    MEA Blood preparation market, by whole blood, 2012 - 2024 (USD Million)
TABLE 156    MEA Blood preparation market, by blood components, 2012 - 2024 (USD Million)
TABLE 157    MEA Blood preparation market, by blood derivatives, 2012 - 2024 (USD Million)
TABLE 158    MEA Blood preparation market, by application, 2012 - 2024 (USD Million)
TABLE 159    MEA Blood preparation market, by antithrombotic and anticoagulants, 2012 - 2024 (USD Million)
TABLE 160    MEA Blood preparation market, by platelet aggregation inhibitors, 2012 - 2024 (USD Million)
TABLE 161    MEA Blood preparation market, by fibrinolytic, 2012 - 2024 (USD Million)
TABLE 162    MEA Blood preparation market, by anticoagulants, 2012 - 2024 (USD Million)
TABLE 163    MEA Blood preparation market, by heparin, 2012 - 2024 (USD Million)
TABLE 164    South Africa Blood preparation market, by product, 2012 - 2024 (USD Million)
TABLE 165    South Africa Blood preparation market, by whole blood, 2012 - 2024 (USD Million)
TABLE 166    South Africa Blood preparation market, by blood components, 2012 - 2024 (USD Million)
TABLE 167    South Africa Blood preparation market, by blood derivatives, 2012 - 2024 (USD Million)
TABLE 168    South Africa Blood preparation market, by application, 2012 - 2024 (USD Million)
TABLE 169    South Africa Blood preparation market, by antithrombotic and anticoagulants, 2012 - 2024 (USD Million)
TABLE 170    South Africa Blood preparation market, by platelet aggregation inhibitors, 2012 - 2024 (USD Million)
TABLE 171    South Africa Blood preparation market, by fibrinolytic, 2012 - 2024 (USD Million)
TABLE 172    South Africa Blood preparation market, by anticoagulants, 2012 - 2024 (USD Million)
TABLE 173    South Africa Blood preparation market, by heparin, 2012 - 2024 (USD Million)

Charts & Figures
FIG. 1   Industry Segmentation        
FIG. 2   Global Blood preparation market, (USD Million), 2012 - 2024 
FIG. 3   Industry Impact forces 
FIG. 5   Growth potential analysis, 2015         
FIG. 6   Blood preparation Porter’s analysis  
FIG. 7   Blood preparation PESTEL analysis
FIG. 8   Red blood cell use by hospital service in 2011
FIG. 9   Platelet use by hospital service in 2011
FIG.10   Global plasma fraction demand in 2010
FIG.11   Global population growth, by age-group, 2012 – 2020 (Million)
FIG.12   Population aged 65+ as percentage of total population, 2010– 2030 (percentage)
FIG.13   Key opportunities prioritized, 2015         
FIG.14   Blood preparation Porter’s analysis  
FIG.15   Blood preparation PESTEL analysis

 

Why Global Market Insights?

 Comprehensive Research
  • All-inclusive coverage
  • In-depth and granular data (ex: information for 8 to 15 countries, with clients open to add to this list, in each report)
  • Penetrative insights & latest trends
  • Offers holistic understanding of the market
 Data Accuracy & Reliability
  • Unique methodology
  • Iterative in nature to eliminate errors
  • Detailed methodology, scope, assumptions and data sources available for reference
 Post-Sales Support
  • Committed to making a positive difference for our clients
  • Given the nature of this industry, we are committed to ensure that our clients get maximum return on their investment in our services
  • Every purchase comes with an option to obtain additional information:
    • up to 10% of the original cost
    • 45-minute analyst tele-call to obtain further clarity on the market.
 Security & Confidentiality
  • Global Market Insights, Inc. strictly adheres to PCI-DSS security norms.
  • Only PCI-DSS compliant payment methods used for highest level of client data security

Tailor this report

Customize this report to suit your needs, speak to our research team to avail these benefits


Connect with our sales team